Thomas Gildea, M.D.
| Appointed: |
2003 |
| Gender: |
Male |
| Languages: |
English |
Pulmonary, Allergy and Critical Care Medicine
Transplantation Center
Biographical Sketch
Thomas Robert Gildea, MD, FCCP, was appointed to Cleveland Clinic in 2003 in the Advanced Lung Disease Section of the Department of Pulmonary Allergy and Critical Care Medicine.
He is board-certified in internal medicine, pulmonary disease and critical care medicine. As a Chief Resident in the Yale Primary Care Internal Medicine residency, he went to Russia in a faculty exchange program to lecture and demonstrate American medical team structure and the basics of clinical epidemiology.
He has advanced training in interventional and advanced diagnostic bronchoscopy, which was part of his fellowship training at Cleveland Clinic. His clinical interests span the realm of advanced lung diseases, including lung volume reduction, lung transplantation, pulmonary arterial hypertension and are most focused on advanced diagnostic and therapeutic bronchoscopy.
Dr. Gildea was the first physician in North America to perform electromagnetic navigation bronchoscopy. He was given an Innovator Award at Cleveland Clinic in 2005 with his team proposing a novel device for a bronchoscopy needle-delivered fiducial lung implant. He has been named one of the Best Doctors in America. He also received a physician development award by the AlphaOne Foundation to study lung function changes after lung transplantation. Under his co-direction, the Center for Major Airway Diseases has brought together teams from Thoracic surgery and ENT for complex airway disease management.
An invited lecturer at national and international medical meetings, Dr. Gildea is recognized expert in the field on interventional pulmonary medicine.
Professional Highlights
- Cleveland Clinic Innovator Award, 2005
Education & Fellowships
| Medical School: | MCP Hahnemann University School of Medicine, Philadelphia, PA |
|
| Internship: | Yale-New Haven Hospital, Internal Medicine, New Haven, CT |
| Residency: | Yale-New Haven Hospital, Internal Medicine, New Haven, CT |
| Fellowship: | Cleveland Clinic, Pulmonary / Critical Care Medi, Cleveland, OH |
| Other Education: | (Undergraduate) University of Scranton, PA |
Additional Training
- Clinical Research Scholars Program, Case Western Reserve University, Masters in Clinical Research program
Certifications
Critical Care Medicine
Pulmonary Disease
Internal Medicine
Specialty Interests
Advanced diagnostic and therapeutic bronchoscopy, interventional pulmonary medicine, lung volume reduction, lung transplantation, Alpha-1 antitrypsin deficiency.
Innovations & Patents
First physician in North America to perform electromagnetic navigation bronchoscopy
Awards & Honors
- Best Doctors in America, 2007-2008
- Physician Development Award, AlphaOne Foundation, 2006-2008
- Finalist, 2004 CHEST Foundation Best Poster in Category Award
- Clinical Research Award Finalist, American College of Chest Physicians, Chest Foundation, 2002
Professional Memberships
- American Thoracic Society
- Fellow, American College of Chest Physicians
- American Association for Bronchology
- World Association for Bronchology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/4/2008, Dr. Gildea has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Gildea receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Equity. Dr. Gildea owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
